NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?
- 22 October 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 12 (21), 4020-4036
- https://doi.org/10.1021/acschemneuro.1c00348
Abstract
Synthetic cannabinoid receptor agonists (SCRAs) remain a prolific class of new psychoactive substances (NPS) and continue to expand rapidly. Despite the recent identification of hydroxybenzotriazole (HOBt) containing SCRAs in synthetic cannabis samples, there is currently no information regarding the pharmacological profile of these NPS with respect to human CB1 and CB2 receptors. In the current study, a series consisting of seven HOBt indole-, indazole-, and 7-azaindole-carboxylates bearing a range of N-alkyl substituents were synthesized and pharmacologically evaluated. Competitive binding assays at CB1 and CB2 demonstrated that all analogues except a 2-methyl-substituted derivative had low affinity for CB1 (Ki = 3.80–43.7 μM) and CB2 (Ki = 2.75–18.2 μM). A fluorometric functional assay revealed that 2-methylindole- and indole-derived HOBt carboxylates were potent and efficacious agonists of CB1 (EC50 = 12.0 and 63.7 nM; Emax = 118 and 120%) and CB2 (EC50 = 10.9 and 321 nM; Emax = 91 and 126%). All other analogues incorporating indazole and 7-azaindole cores and bearing a range of N1-substituents showed relatively low potency for CB1 and CB2. Additionally, a reporter assay monitoring β-arrestin 2 (βarr2) recruitment to the receptor revealed that the 2-methylindole example was the most potent and efficacious at CB1 (EC50 = 131 nM; Emax = 724%) and the most potent at CB2 (EC50 = 38.2 nM; Emax = 51%). As with the membrane potential assay, the indazole and other indole HOBt carboxylates were considerably less potent at both receptors, and analogues comprising a 7-azaindole core showed little activity. Taken together, these data suggest that NNL-3 demonstrates little CB1 receptor activity and is unlikely to be psychoactive in humans. NNL-3 is likely an unintended SCRA manufacturing byproduct. However, the synthesis of NNL-3 analogues proved simple and general, and some of these showed potent cannabimetic profiles in vitro, indicating that HOBt esters of this type may represent an emerging class of SCRA NPS.Keywords
Funding Information
- Schweizerischer Nationalfonds zur F??rderung der Wissenschaftlichen Forschung (SNF_P2BEP3_191780)
- National Health and Medical Research Council (1161571)
- Health Research Council of New Zealand
- Fonds Wetenschappelijk Onderzoek (1S5421N)
- Lambert Initiative for Cannabinoid Therapeutics
- Brain and Mind Centre Research Development Grant
This publication has 76 references indexed in Scilit:
- Ligands and signaling proteins govern the conformational landscape explored by a G protein-coupled receptorProceedings of the National Academy of Sciences of the United States of America, 2012
- Peptide Coupling Reagents, More than a Letter SoupChemical Reviews, 2011
- PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa PredictionsJournal of Chemical Theory and Computation, 2011
- ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs?Journal of Mass Spectrometry, 2009
- The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 2008
- Epik: a software program for pK a prediction and protonation state generation for drug-like moleculesJournal of Computer-Aided Molecular Design, 2007
- Novel Procedure for Modeling Ligand/Receptor Induced Fit EffectsJournal of Medicinal Chemistry, 2005
- International Union of Pharmacology. XXVII. Classification of Cannabinoid ReceptorsPharmacological Reviews, 2002
- Pharmacology of cannabinoid CB1 and CB2 receptorsPharmacology & Therapeutics, 1997
- Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic LiquidsJournal of the American Chemical Society, 1996